C07D 233/84
Sulfur atoms
C07D233/84 (Sulfur atoms) appears on 674 US grants and 399 published applications in this corpus.
Search patents in C07D- Granted patents
- 674
- Published applications
- 399
- Assignees
- 284
- Inventors
- 1,569
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 10 | 0 |
| 1978 | 8 | 0 |
| 1979 | 8 | 0 |
| 1980 | 20 | 0 |
| 1981 | 14 | 0 |
| 1982 | 5 | 0 |
| 1983 | 12 | 0 |
| 1984 | 10 | 0 |
| 1985 | 10 | 0 |
| 1986 | 7 | 0 |
| 1987 | 12 | 0 |
| 1988 | 9 | 0 |
| 1989 | 15 | 0 |
| 1990 | 23 | 0 |
| 1991 | 19 | 0 |
| 1992 | 24 | 0 |
| 1993 | 21 | 0 |
| 1994 | 18 | 0 |
| 1995 | 17 | 0 |
| 1996 | 23 | 0 |
| 1997 | 31 | 0 |
| 1998 | 13 | 0 |
| 1999 | 13 | 0 |
| 2000 | 18 | 0 |
| 2001 | 14 | 0 |
| 2002 | 16 | 20 |
| 2003 | 16 | 34 |
| 2004 | 11 | 24 |
| 2005 | 15 | 23 |
| 2006 | 15 | 25 |
| 2007 | 21 | 23 |
| 2008 | 15 | 25 |
| 2009 | 12 | 17 |
| 2010 | 11 | 20 |
| 2011 | 20 | 19 |
| 2012 | 11 | 23 |
| 2013 | 15 | 18 |
| 2014 | 26 | 16 |
| 2015 | 16 | 14 |
| 2016 | 11 | 11 |
| 2017 | 12 | 17 |
| 2018 | 7 | 7 |
| 2019 | 7 | 4 |
| 2020 | 8 | 16 |
| 2021 | 6 | 10 |
| 2022 | 5 | 8 |
| 2023 | 2 | 10 |
| 2024 | 9 | 5 |
| 2025 | 3 | 5 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and materials for inhibiting NF-kB activity21 Apr 2026US 12,606,528 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Heteroaryl-thio-substituted pyrones9 Dec 2025US 12,492,341 B2Iowa State University Research Foundation, Inc.
- Inhibitors of nitric oxide synthases (NOS), pharmaceutical products thereof, and methods thereof10 Jun 2025US 12,325,681 B2Gacter Inc.
- Non-aqueous electrolyte solution additive, and non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery which include the same14 Jan 2025US 12,195,431 B2LG Energy Solution, Ltd.
- Heteroaryl-thio-substituted pyrones17 Sep 2024US 12,091,602 B2Iowa State University Research Foundation, Inc.
- Compounds, compositions and uses thereof in the treatment and prevention of diseases and conditions associate with or aggravated by impaired mitophagy or oxidative stress30 Jul 2026US 2026/0217659 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Light-emitting device including organic compound, electronic apparatus and electronic device including the light-emitting device, and the organic compound14 May 2026US 2026/0136827 A1Samsung Display Co., Ltd.
- Crystal form of ergothioneine26 Mar 2026US 2026/0085049 A1Nanjing Nutrabuilding Bio-Tech Co., Ltd.
- Polymorphic form of nepicastat acid addition salt, preparation method therefor and use thereof5 Mar 2026US 2026/0062388 A1Asieris Pharmaceuticals (Shanghai) Co., Ltd.
- Low-odor, high-stability ergothioneine crystal26 Feb 2026US 2026/0055064 A1Gene III Biotechnology Co., Ltd.
Most cited
By later US patents
- Amide derivatives176US 4,636,505 AImperial Chemical Industries PLC · 1987
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Angiotensin II receptor blocking imidazoles119US 5,138,069 AE. I. Du Pont de Nemours and Company · 1992
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Pharmacologically active guanidine compounds97US 3,950,333 ASmith Kline & French Laboratories Limited · 1976